TLR4 and breast cancer: Indeed, our findings reveal for the first time that TNBC cell aggressiveness is fostered by a PTX3/TLR4 autocrine loop of stimulation, and that its inhibition may represent a promising therapeutic approach for the treatment of the most dangerous BC subtype.